Karyopharm Therapeutics, Inc. (KPTI)
7.35
+0.04
(+0.55%)
USD |
NASDAQ |
Dec 31, 11:04
Karyopharm Therapeutics Market Cap: 125.32M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bruker Corp. | 7.155B |
| TG Therapeutics, Inc. | 4.701B |
| Actinium Pharmaceuticals, Inc. | 43.05M |
| Axsome Therapeutics, Inc. | 8.915B |
| Krystal Biotech, Inc. | 7.159B |
Market Cap Related Metrics
| PS Ratio | 0.4403 |
| PEG Ratio | -0.0004 |
| Price | 7.35 |
| Earnings Yield | -198.4% |
| PEGY Ratio | -0.0004 |